| Jonathan Arthur Cheek, MD | |
|
134 Riverstone Terrace, Suite 103, Canton, GA 30114-1705 | |
| (770) 479-1985 | |
| (770) 479-4839 |
| Full Name | Jonathan Arthur Cheek |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 134 Riverstone Terrace, Canton, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073574554 | NPI | - | NPPES |
| 000306765A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 027700 (Georgia) | Primary |
| 208000000X | Pediatrics | G50918 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Arthur Cheek, MD 15 Reinhardt College Pkwy, Bldg 100 Suite 100, Canton, GA 30114 Ph: (770) 479-1985 | Jonathan Arthur Cheek, MD 134 Riverstone Terrace, Suite 103, Canton, GA 30114-1705 Ph: (770) 479-1985 |
News Archive
A survey carried out earlier this year has found the first evidence of the 'superbug' bacteria Methicillin-Resistant Staphylococcus aureus (MRSA) in sausages and minced pork obtained from supermarkets in the UK. However, researchers stress that this does not pose a significant immediate risk to the public.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
GlaxoSmithKline today said it had posted a strong performance in a challenging year with a return to sales growth for the first time since 2007.
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced it has launched the breakthrough WaferGen SmartChip Real-Time PCR System, the next-generation Real-Time PCR system for discovery and validation of biomarkers, or gene expression patterns, on a single platform. The SmartChip System is designed to provide accurate, highly sensitive and high-throughput gene expression profiling capabilities to researchers, clinicians and pharmaceutical companies.
Northwest Biotherapeutics, a U.S. biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, confirmed today that its Phase III trial of DCVax-L for newly diagnosed glioblastoma multiforme (GBM) is ongoing and the patients enrolled in the trial are continuing to be treated per the protocol.
› Verified 1 days ago
Dr. Vicki D Knight-mathis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2920 Marietta Hwy, Suite 142, Canton, GA 30114 Phone: 770-704-0057 Fax: 770-704-0223 | |
Aaron Robert Millage, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-720-5100 | |
Dr. Michael George Anderson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 391 East Main Street, Historic Hawkins Building, Canton, GA 30114 Phone: 770-720-6963 Fax: 770-720-6965 | |
Nicholas Kelly, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1558 Riverstone Pkwy Ste 100, Canton, GA 30114 Phone: 404-785-5437 Fax: 404-785-4683 | |
Anthony David Wahbeh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1558 Riverstone Pkwy Ste 100, Canton, GA 30114 Phone: 404-785-5437 Fax: 404-785-4683 | |
Dr. Enid Colon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 205 Waleska Rd Ste 1c, Canton, GA 30114 Phone: 770-345-0055 Fax: 770-345-0020 |